At the TERMIS-EU 2026 Congress, STRONG-UR joined the broader tissue engineering community to share progress and exchange perspectives on one of the field’s central challenges: translating research into clinical impact.
Through symposium presentations and poster sessions, the project contributed to ongoing discussions around biofabrication and tissue engineering approaches for regenerative medicine.
A key takeaway from the event was the importance of aligning material design and biofabrication strategies with clinical needs. Feedback received during the congress, particularly around translational aspects, highlighted both the progress made in the field and the complexity of moving from laboratory results to real-world applications.
Engagements with researchers and clinicians also showed that many teams are addressing similar challenges from different angles, reinforcing the value of interdisciplinary collaboration in advancing the field.
For STRONG-UR, these discussions provide useful direction as the project continues to develop bioprinting-based solutions for tissue reconstruction, with a focus on clinically relevant applications.
